Cargando…
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study
AIMS: To determine the global extent of hypoglycaemia experienced by patients with diabetes using insulin, as there is a lack of data on the prevalence of hypoglycaemia in developed and developing countries. METHODS: This non‐interventional, multicentre, 6‐month retrospective and 4‐week prospective...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031206/ https://www.ncbi.nlm.nih.gov/pubmed/27161418 http://dx.doi.org/10.1111/dom.12689 |
_version_ | 1782454765262733312 |
---|---|
author | Khunti, K. Alsifri, S. Aronson, R. Cigrovski Berković, M. Enters‐Weijnen, C. Forsén, T. Galstyan, G. Geelhoed‐Duijvestijn, P. Goldfracht, M. Gydesen, H. Kapur, R. Lalic, N. Ludvik, B. Moberg, E. Pedersen‐Bjergaard, U. Ramachandran, A. |
author_facet | Khunti, K. Alsifri, S. Aronson, R. Cigrovski Berković, M. Enters‐Weijnen, C. Forsén, T. Galstyan, G. Geelhoed‐Duijvestijn, P. Goldfracht, M. Gydesen, H. Kapur, R. Lalic, N. Ludvik, B. Moberg, E. Pedersen‐Bjergaard, U. Ramachandran, A. |
author_sort | Khunti, K. |
collection | PubMed |
description | AIMS: To determine the global extent of hypoglycaemia experienced by patients with diabetes using insulin, as there is a lack of data on the prevalence of hypoglycaemia in developed and developing countries. METHODS: This non‐interventional, multicentre, 6‐month retrospective and 4‐week prospective study using self‐assessment questionnaire and patient diaries included 27 585 patients, aged ≥18 years, with type 1 diabetes (T1D; n = 8022) or type 2 diabetes (T2D; n = 19 563) treated with insulin for >12 months, at 2004 sites in 24 countries worldwide. The primary endpoint was the proportion of patients experiencing at least one hypoglycaemic event during the observational period. RESULTS: During the prospective period, 83.0% of patients with T1D and 46.5% of patients with T2D reported hypoglycaemia. Rates of any, nocturnal and severe hypoglycaemia were 73.3 [95% confidence interval (CI) 72.6–74.0], 11.3 (95% CI 11.0–11.6) and 4.9 (95% CI 4.7–5.1) events/patient‐year for T1D and 19.3 (95% CI 19.1–19.6), 3.7 (95% CI 3.6–3.8) and 2.5 events/patient‐year (95% CI 2.4–2.5) for T2D, respectively. The highest rates of any hypoglycaemia were observed in Latin America for T1D and Russia for T2D. Glycated haemoglobin level was not a significant predictor of hypoglycaemia. CONCLUSIONS: We report hypoglycaemia rates in a global population, including those in countries without previous data. Overall hypoglycaemia rates were high, with large variations between geographical regions. Further investigation into these differences may help to optimize therapy and reduce the risk of hypoglycaemia. |
format | Online Article Text |
id | pubmed-5031206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-50312062016-10-03 Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study Khunti, K. Alsifri, S. Aronson, R. Cigrovski Berković, M. Enters‐Weijnen, C. Forsén, T. Galstyan, G. Geelhoed‐Duijvestijn, P. Goldfracht, M. Gydesen, H. Kapur, R. Lalic, N. Ludvik, B. Moberg, E. Pedersen‐Bjergaard, U. Ramachandran, A. Diabetes Obes Metab Original Articles AIMS: To determine the global extent of hypoglycaemia experienced by patients with diabetes using insulin, as there is a lack of data on the prevalence of hypoglycaemia in developed and developing countries. METHODS: This non‐interventional, multicentre, 6‐month retrospective and 4‐week prospective study using self‐assessment questionnaire and patient diaries included 27 585 patients, aged ≥18 years, with type 1 diabetes (T1D; n = 8022) or type 2 diabetes (T2D; n = 19 563) treated with insulin for >12 months, at 2004 sites in 24 countries worldwide. The primary endpoint was the proportion of patients experiencing at least one hypoglycaemic event during the observational period. RESULTS: During the prospective period, 83.0% of patients with T1D and 46.5% of patients with T2D reported hypoglycaemia. Rates of any, nocturnal and severe hypoglycaemia were 73.3 [95% confidence interval (CI) 72.6–74.0], 11.3 (95% CI 11.0–11.6) and 4.9 (95% CI 4.7–5.1) events/patient‐year for T1D and 19.3 (95% CI 19.1–19.6), 3.7 (95% CI 3.6–3.8) and 2.5 events/patient‐year (95% CI 2.4–2.5) for T2D, respectively. The highest rates of any hypoglycaemia were observed in Latin America for T1D and Russia for T2D. Glycated haemoglobin level was not a significant predictor of hypoglycaemia. CONCLUSIONS: We report hypoglycaemia rates in a global population, including those in countries without previous data. Overall hypoglycaemia rates were high, with large variations between geographical regions. Further investigation into these differences may help to optimize therapy and reduce the risk of hypoglycaemia. Blackwell Publishing Ltd 2016-06-20 2016-09 /pmc/articles/PMC5031206/ /pubmed/27161418 http://dx.doi.org/10.1111/dom.12689 Text en © 2016 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Khunti, K. Alsifri, S. Aronson, R. Cigrovski Berković, M. Enters‐Weijnen, C. Forsén, T. Galstyan, G. Geelhoed‐Duijvestijn, P. Goldfracht, M. Gydesen, H. Kapur, R. Lalic, N. Ludvik, B. Moberg, E. Pedersen‐Bjergaard, U. Ramachandran, A. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study |
title | Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study |
title_full | Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study |
title_fullStr | Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study |
title_full_unstemmed | Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study |
title_short | Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study |
title_sort | rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global hat study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031206/ https://www.ncbi.nlm.nih.gov/pubmed/27161418 http://dx.doi.org/10.1111/dom.12689 |
work_keys_str_mv | AT khuntik ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT alsifris ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT aronsonr ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT cigrovskiberkovicm ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT entersweijnenc ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT forsent ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT galstyang ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT geelhoedduijvestijnp ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT goldfrachtm ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT gydesenh ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT kapurr ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT lalicn ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT ludvikb ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT moberge ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT pedersenbjergaardu ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT ramachandrana ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy AT ratesandpredictorsofhypoglycaemiain27585peoplefrom24countrieswithinsulintreatedtype1andtype2diabetestheglobalhatstudy |